EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs

Yoonhee Kim, Wonhee Lee, Byunggak Kim, Bonghwan Jang, Kyung-Rok Yu, Hong Sook Kim, Minok Ryu iD, Yein Oh iD, Kyoungwon Seo iD, Chul Park, Ulsoo Choi iD, Dongha Bhang iD und 1 weitere

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.17266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Veterinary Internal Medicine, 2025. Verfasst von Yoonhee Kim und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Clinical Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollabuk-do, Republic of Korea. Hauptthemen laut MEDLINE: Thymidine Kinase, Dog Diseases, Autoantibodies, Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Biattic Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although the importance of early diagnosis of malignant tumors is a major concern, an easily accessible in-house method has not been established.

Objectives

To investigate the most optimal model by combining thymidine kinase 1 (TK1) autoantibody, extracellular protein kinase A (ECPKA) autoantibody, TK1 antigen, C-reactive protein (CRP), age, breed, and sex. Animals Serum samples from 1702 dogs were collected from local animal hospitals and referral animal medical centers in Korea.

Methods

TK1 autoantibody, ECPKA autoantibody, and CRP were measured using LFIA methods in serum samples of dog to design a new neoplastic index (NI) for early detection of malignant tumors in dogs.

Results

AUC of TK1 autoantibody model with TK1 antigen, CRP, age, and breed in multiple logistic regression analysis was 0.966 (TK1 autoantibody, P = .0005; TK1 antigen, P = .0003), and when the cutoff value was 0.417, the specificity was 87.1%, and sensitivity was 96.4%. Regression coefficients were 24.4, 20.5, 24.8, 10.6, respectively in TK1 autoantibody, TK1 antigen, CRP, and age, and the effect by breed (regression coefficient 2.1, 3.0) was the lowest. The same multiple logistic regression analysis on dogs with lymphoma, and AUC of TK1 autoantibody model was 0.981 (all P < .0001, TK1 antigen P = .09), when the cutoff value was 0.352, the specificity was 92.9%, and sensitivity was 93.7%. Conclusions and Clinical Importance The NI including TK1 autoantibody could be useful in the screening test for both lymphoma and other tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thymidine KinaseDog DiseasesAutoantibodiesNeoplasmsC-Reactive ProteinAnimalsDogsFemaleMaleEarly Detection of CancerSensitivity and SpecificityBiomarkers, Tumor

Stichwörter der Autor:innen

C‐reactive proteinautoantibodiesextracellular protein kinase Amalignant tumorneoplastic indexthymidine kinase 1

Substanzen

Thymidine Kinasethymidine kinase 1AutoantibodiesC-Reactive ProteinBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Veterinary Clinical Pathology, College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollabuk-do, Republic of Korea.
  • Biattic Inc., #306, 16, Heungan-daero 427beon-gil, Dongan-gu, Anyang-si, Gyeonggi-do, Republic of Korea.
  • Good-Morning-Pet Animal Hospital, Jeongjail-ro 55, Bundang-gu, Seongnam-si, Gyeonggi-do, Seoul, South Korea.
  • Department of Agricultural Biotechnology and Research Institute of Agriculture and Life Sciences, Seoul National University, Seoul, South Korea.
  • Department of Biological Sciences, Sungkyunkwan University, 2066 Seobu-ro, Jangan-gu, Suwon, Gyeonggi-do, South Korea.
  • Seoul National University College of Veterinary Medicine, 1 Gwanak-ro, Gwanak-gu, Seoul, South Korea.

ORCID-Profile: Minok Ryu, Yein Oh, Kyoungwon Seo, Ulsoo Choi, Dongha Bhang, Hwayoung Youn

Förderung

  • Biattic Inc.

Zitieren

APA

Kim, Y., Lee, W., Kim, B., Jang, B., Yu, K. R., Kim, H. S., Ryu, M., Oh, Y., Seo, K., Park, C., Choi, U., Bhang, D., & Youn, H. (2025). Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.17266

Vancouver

Kim Y, Lee W, Kim B, Jang B, Yu KR, Kim HS, et al. Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.17266

BibTeX
@article{Kim2025,
  author = {Kim, Yoonhee and Lee, Wonhee and Kim, Byunggak and Jang, Bonghwan and Yu, Kyung-Rok and Kim, Hong Sook and Ryu, Minok and Oh, Yein and Seo, Kyoungwon and Park, Chul and Choi, Ulsoo and Bhang, Dongha and Youn, Hwayoung},
  title = {Use of thymidine kinase 1 autoantibody, thymidine kinase antigen, extracellular protein kinase A autoantibody, and C-reactive protein for early detection of malignant tumors in dogs},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.17266}
}
Kostenlos starten →